Výsledky vyhledávání - "Carmen de Cos"

Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients

Autor: Ramón Rodríguez-González, José Ramón González-Porras, Raquel Garrido, Pascual Marco, Faustino García-Candel, Maria Eva Mingot-Castellano, Andrés Moret, María Fernanda López-Fernández, Laura Quintana, Carmen de Cos

Publikováno v: BLOOD COAGULATION & FIBRINOLYSIS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante

We hypothesized that inhibitor specificity may predict the outcome of antifactor VIII autoantibodies eradication treatment in acquired hemophilia A. Our objective was to analyze the association between factor VIII domains recognized by inhibitors and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eefcb2acbe21f3ae94d8bc1c12d7c7e8
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10800

Zobrazit plný text záznamu

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

Autor: María Perera, Montserrat Cortés, Erika Coria, Miguel Angel Fuertes-Palacio, Laura Solán, Isabel Caparrós, Inés Valcarce, Isidro Jarque, Carlos Aguilar, R. Jiménez, Pilar Galan, Silvia Bernat, Tomás José González-López, Pável E Olivera, Mónica Martín-Salces, Adriana Sainz, María Carmen Arratibel, María Paz Martínez-Badas, Maria Eva Mingot-Castellano, Manuel González-Silva, Fernando Fernández-Fuertes, Rafael Feito Alonso, Erik de Cabo, Juan Andrés Vázquez-Paganini, Angeles Fernández-Rodríguez, Susana Pérez-Crespo, Paola Beneit, Carmen Fernández-Miñano, Rosa Fisac, Carmen de Cos, Maria José Cortti, Violeta Martínez-Robles, Jose Angel Hernandez-Rivas, Alberto Casaus, Armando Luaña, Isabel Gutierrez-Jomarrón, Arancha Alonso, Cristina Fernández-Canal, María Teresa Álvarez-Román, María Jesús Peñarrubia, Javier García-Frade, Marcio M Andrade, José Ramón González-Porras, Marta Gómez-Nuñez, María Calbacho, Gloria Pérez-Rus, Cristina Pascual, Blanca Sanchez-Gonzalez

Publikováno v: American Journal of Hematology. 90:E40-E43

Eltrombopag is effective and safe in immune thrombocytopenia (ITP). Some patients may sustain their platelet response when treatment is withdrawn but the frequency of this phenomenon is unknown. We retrospectively evaluated 260 adult primary ITP pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51bdd0e8fe6218ff5b4f6f1ed793dbab
https://doi.org/10.1002/ajh.23900

Zobrazit plný text záznamu

Successful immune tolerance induction with a plasma-derived FVIII concentrate and intravenous immunoglobulins in a pediatric patient with congenital severe hemophilia A and poor prognostic factors

Autor: Javier Rodríguez-Martorell, Carmen de Cos

Publikováno v: Blood Coagulation & Fibrinolysis. 25:77-80

We present the case of a pediatric patient born in July 1991, diagnosed with severe hemophilia A at 8 months of life after a hemarthrosis. He was treated with regular factor replacement therapy on-demand until an inhibitor was detected (1.75-2.5 BU)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ae67e6db3c7b6d3a419d709820ba833
https://doi.org/10.1097/mbc.0b013e328364f992

Zobrazit plný text záznamu

Antithrombin Dublin (p.Val30Glu):a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency

Autor: Juan Souto, María Eugenia de la Morena-Barrio, Pilar Llamas, José Navarro-Fernández, Carmen de Cos, José Padilla, Kim Overvad, Teresa Sevivas, Nuria Fernández-Mosteirín, Sonia Aguila, Pilar Medina, Vicente Vicente, Irene Martínez-Martínez, Antonia Miñano, Nataliya Bohdan, Javier Corral, Susana Asenjo, Søren Risom Kristensen

Publikováno v: Navarro-Fernandez, J, de la Morena-Barrio, M E, Padilla, J, Miñano, A, Bohdan, N, Águila, S, Martínez-Martínez, I, Sevivas, T S, de Cos, C, Fernández-Mosteirín, N, Llamas, P, Asenjo, S, Medina, P, Souto, J C, Overvad, K, Kristensen, S R, Corral, J & Vicente, V 2016, ' Antithrombin Dublin (p.Val30Glu) : a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency ', Thrombosis and Haemostasis, vol. 116, no. 1, pp. 146-154 . https://doi.org/10.1160/TH15-11-0871
Navarro-Fernandez, J, de la Morena-Barrio, M E, Padilla, J, Miñano, A, Bohdan, N, Águila, S, Martínez-Martínez, I, Sevivas, T S, de Cos, C, Fernández-Mosteirín, N, Llamas, P, Asenjo, S, Medina, P, Souto, J C, Overvad, K, Kristensen, S R, Corral, J & Vicente, V 2016, ' Antithrombin Dublin (p.Val30Glu) : a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency ', Thrombosis and Haemostasis, vol. 116, no. 1, pp. 146-54 . https://doi.org/10.1160/TH15-11-0871

SummaryThe key haemostatic role of antithrombin and the risk of thrombosis associated with its deficiency support that the low incidence of antithrombin deficiency among patients with thrombosis might be explained by underestimation of this disorder.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0aa1f206b6d7e40dca3fe2a6dc60eed
https://vbn.aau.dk/da/publications/e7f89f18-9d09-4d8b-9175-7e4e7e622f77

Zobrazit plný text záznamu

Use of Eltrombopag after Romiplostim in Primary ITP Patients

Autor: Manuel González-Silva, Angeles Fernández-Rodríguez, Susana Pérez-Crespo, Erika Coria, Silvia Bernat, Violeta Martínez-Robles, Marta Gómez-Nuñez, María Eva Mingot, Pilar Galan, Rosa Fisac, María Perera, Cristina Fernández-Canal, Gloria Pérez-Rus, Rafael Feito Alonso, Miguel Angel Fuertes-Palacio, Carmen de Cos, Cristina Pascual, María Calbacho, Carmen Fernández-Miñano, María Carmen Arratibel, Carlos Aguilar, Laura Solán, Isabel Caparrós, Fernando Fernández-Fuentes, Tomás José González-López, María Paz Martínez-Badas, José Ramón González-Porras, Juan Andrés Vázquez-Paganini, Montserrat Cortés, Maria José Cortti, Francisco Javier Díaz-Gálvez, Paola Beneit, Isidro Jarque, Luis Miguel Juárez-Salcedo, Jose Angel Hernandez-Rivas, Alberto Casaus, Adriana Sainz, R. Jiménez, Javier García-Frade, Marcio M Andrade, Armando Luaña, María Teresa Álvarez-Román, Inés Valcarce, Blanca Sanchez-Gonzalez, Pável E Olivera, Arancha Alonso, Mónica Martín-Salces, María Jesús Peñarrubia

Publikováno v: Blood. 124:2790-2790

Background: The trombopoietin receptor agonists (TRAs) romiplostim and eltrombopag are effective and safe in the treatment of chronic immune thrombocytopenia (ITP). However, when no response is achieved or when adverse events occur with one TRA the v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::91dab2ddcc894fc8c8e5e1009b100756
https://doi.org/10.1182/blood.v124.21.2790.2790

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání